CN1822843B - 制备含有抗病毒药物颗粒的方法 - Google Patents
制备含有抗病毒药物颗粒的方法 Download PDFInfo
- Publication number
- CN1822843B CN1822843B CN2004800205148A CN200480020514A CN1822843B CN 1822843 B CN1822843 B CN 1822843B CN 2004800205148 A CN2004800205148 A CN 2004800205148A CN 200480020514 A CN200480020514 A CN 200480020514A CN 1822843 B CN1822843 B CN 1822843B
- Authority
- CN
- China
- Prior art keywords
- amino
- alkyl
- group
- granule
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Abstract
Description
化合物号 | R<sup>3</sup> | R<sup>4</sup> |
1 | -CH=CH-CN | H |
2 | -C(CH<sub>3</sub>)=CH-CN | H |
3 | -CH=C(CH<sub>3</sub>)-CN | H |
化合物号 | R<sup>3</sup> | R<sup>1</sup> |
4 | -CH=CH-CN | H |
5 | -CH=C(CH<sub>3</sub>)-CN | H |
化合物号 | R<sup>3</sup> | R<sup>4a</sup> | R<sup>4b</sup> | X<sup>1</sup> |
6 | -CH=C(CH<sub>3</sub>)-CN | CH<sub>3</sub> | Cl | -NH |
7 | -CH=CH-CN | CH<sub>3</sub> | 2-呋喃 | -NH |
8 | -CH=C(CH<sub>3</sub>)-CN | CH<sub>3</sub> | Br | -NH |
化合物号 | R<sup>3</sup> | R<sup>4a</sup> | R<sup>4b</sup> | X<sup>1</sup> |
9 | -CH=CH-CN | CH<sub>3</sub> | Br | -NH |
10 | -CH=CH-CN | CH<sub>3</sub> | Cl | -NH |
原材料 | 量(kg) |
TMC125 | 11.67 |
HPMC 2910 5cPs | 35.00 |
Montanox 20DF | 1.17 |
二氯甲烷 | 860.00 |
96%乙醇 | 83.33 |
总计 | 991.17 |
原材料 | 量(kg) | 百分数(%) |
TMC125 | 70 | 20 |
乳糖EFK | 63 | 18 |
HPMC 2910 5cPs | 210 | 60 |
Montanox 20DF | 7 | 2 |
二氯甲烷 | 5160 | / |
96%乙醇 | 500 | / |
总计 | 350 | 100 |
赋形剂 | 量(mg) | 百分数(%) |
TMC125粒料 | 1000.00 | 76.92 |
微晶纤维素PH302* | 212.90 | 16.38 |
网状聚维酮CL USP | 72.80 | 5.60 |
二氧化硅USP(Aerosil)** | 3.90 | 0.30 |
氢化棉籽油** | 10.40 | 0.80 |
总计 | 1300.00 | 100.00 |
Claims (10)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR03/08720 | 2003-07-17 | ||
FR0308720A FR2857591B1 (fr) | 2003-07-17 | 2003-07-17 | Particules comprenant un principe actif sous forme de co-precipite |
EP04103156 | 2004-07-02 | ||
EP04103156.8 | 2004-07-02 | ||
PCT/EP2004/051545 WO2005011702A1 (en) | 2003-07-17 | 2004-07-19 | Process for preparing particles containing an antiviral |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1822843A CN1822843A (zh) | 2006-08-23 |
CN1822843B true CN1822843B (zh) | 2010-04-28 |
Family
ID=34117539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2004800205148A Active CN1822843B (zh) | 2003-07-17 | 2004-07-19 | 制备含有抗病毒药物颗粒的方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060172010A1 (zh) |
EP (1) | EP1648467B1 (zh) |
CN (1) | CN1822843B (zh) |
BR (1) | BRPI0412734A (zh) |
DK (1) | DK1648467T3 (zh) |
ES (1) | ES2667668T3 (zh) |
WO (1) | WO2005011702A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2029110T3 (pl) * | 2006-06-06 | 2012-03-30 | Janssen Sciences Ireland Uc | Proces wytwarzania suszonych rozpyłowo formulacji TMC125 |
EP2104491B1 (en) | 2006-12-06 | 2017-02-22 | Janssen Sciences Ireland UC | Hydrobromide salt of an anti-hiv compound |
US20110082161A1 (en) * | 2008-06-30 | 2011-04-07 | Lieven Elvire Colette Baert | Powders for reconstitution |
CN101813832B (zh) * | 2010-04-15 | 2011-11-09 | 厦门虹泰光学有限公司 | 抗蓝光茶色太阳镜片 |
US20180228826A1 (en) * | 2015-08-04 | 2018-08-16 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
US20180228828A1 (en) * | 2015-08-04 | 2018-08-16 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
WO2017023715A1 (en) * | 2015-08-04 | 2017-02-09 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
CN114392241B (zh) * | 2022-01-10 | 2023-07-25 | 安徽贝克生物制药有限公司 | 一种利匹韦林片及其制备方法 |
CN114404377B (zh) * | 2022-01-10 | 2023-07-25 | 安徽贝克生物制药有限公司 | 一种阿巴卡韦、拉米夫定、依非韦伦复方片及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776495A (en) * | 1994-07-26 | 1998-07-07 | Laboratoires Effik | Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
EP1103252A1 (en) * | 1998-07-21 | 2001-05-30 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
CN1322198A (zh) * | 1998-11-10 | 2001-11-14 | 詹森药业有限公司 | 抑制hiv复制的嘧啶类 |
CN1406140A (zh) * | 2000-02-28 | 2003-03-26 | 吉倪塞思公司 | 纳米胶囊包封系统与方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016254A (en) * | 1972-05-19 | 1977-04-05 | Beecham Group Limited | Pharmaceutical formulations |
IL124935A (en) * | 1996-05-20 | 2001-06-14 | Janssen Pharmaceutica Nv | Dissolvable fungicidal preparations contain itraconazole with improved bioavailability |
US6027747A (en) * | 1997-11-11 | 2000-02-22 | Terracol; Didier | Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
DK0945443T3 (da) | 1998-03-27 | 2003-06-02 | Janssen Pharmaceutica Nv | HIV-hæmmende pyrimidinderivater |
EP0945447A1 (en) | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
OA12029A (en) | 1999-09-24 | 2006-04-28 | Janssen Pharmaceutica Nv | Antiviral compositions. |
JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
-
2004
- 2004-07-19 BR BRPI0412734-0A patent/BRPI0412734A/pt not_active Application Discontinuation
- 2004-07-19 CN CN2004800205148A patent/CN1822843B/zh active Active
- 2004-07-19 DK DK04766264.8T patent/DK1648467T3/en active
- 2004-07-19 ES ES04766264.8T patent/ES2667668T3/es active Active
- 2004-07-19 WO PCT/EP2004/051545 patent/WO2005011702A1/en active Application Filing
- 2004-07-19 US US10/564,845 patent/US20060172010A1/en not_active Abandoned
- 2004-07-19 EP EP04766264.8A patent/EP1648467B1/en active Active
-
2009
- 2009-09-03 US US12/553,545 patent/US8722696B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776495A (en) * | 1994-07-26 | 1998-07-07 | Laboratoires Effik | Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
EP1103252A1 (en) * | 1998-07-21 | 2001-05-30 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
CN1322198A (zh) * | 1998-11-10 | 2001-11-14 | 詹森药业有限公司 | 抑制hiv复制的嘧啶类 |
CN1406140A (zh) * | 2000-02-28 | 2003-03-26 | 吉倪塞思公司 | 纳米胶囊包封系统与方法 |
Non-Patent Citations (4)
Title |
---|
. |
权利要求6 |
第2页右栏第34行至第3栏第18行 |
说明书第17页第13-16行. |
Also Published As
Publication number | Publication date |
---|---|
WO2005011702A1 (en) | 2005-02-10 |
EP1648467A1 (en) | 2006-04-26 |
CN1822843A (zh) | 2006-08-23 |
BRPI0412734A (pt) | 2006-09-26 |
ES2667668T3 (es) | 2018-05-14 |
US20060172010A1 (en) | 2006-08-03 |
DK1648467T3 (en) | 2018-06-25 |
EP1648467B1 (en) | 2018-03-21 |
US8722696B2 (en) | 2014-05-13 |
US20100062069A1 (en) | 2010-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7241458B1 (en) | Antiviral compositions | |
US8722696B2 (en) | Process for preparing particles containing an antiviral | |
RU2469707C2 (ru) | Фармацевтические композиции, содержащие нилотиниб или его соль | |
JP2003510264A5 (zh) | ||
EP2359813A1 (en) | Pharmaceutical composition comprising N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid | |
JP2009537633A (ja) | 噴霧乾燥によるナノ粒子の製造方法 | |
EP1940357A2 (en) | Pharmaceutical compositions | |
JP7197474B2 (ja) | 分散性組成物 | |
US20080255193A1 (en) | Pharmaceutical Composition | |
US20070178151A1 (en) | Spray dried pharmaceutical compositions | |
CN110917200A (zh) | 一种包含微粉化形式的口服固体药物组合物及其制备方法 | |
MXPA06010860A (en) | Spray dried pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: IRELAND JANSSEN R + D COMPANY Free format text: FORMER OWNER: JANSSEN R + D IRELAND Effective date: 20150723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: JANSSEN R + D IRELAND Free format text: FORMER NAME: TIBOTEC PHARM LTD. Owner name: TIBOTEC PHARM LTD. Free format text: FORMER NAME: TIBOTEC NV |
|
CP01 | Change in the name or title of a patent holder |
Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Address after: The Irish Village Patentee after: TIBOTEC PHARMACEUTICALS Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150723 Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: JANSSEN R&D IRELAND |